Alkylating AgentsCisplatinAntineoplastic Agents, AlkylatingAlkylationO(6)-Methylguanine-DNA MethyltransferaseMethylnitronitrosoguanidineMethyl MethanesulfonateMechlorethamineCarmustineAntineoplastic AgentsChlorambucilEthyl MethanesulfonateDNA RepairDacarbazineNitrogen Mustard CompoundsAntineoplastic Combined Chemotherapy ProtocolsMelphalanDNA DamageGuanineCyclophosphamideDrug Resistance, NeoplasmMethylnitrosoureaSulfuric Acid EstersDrug ResistanceDNA AdductsMitomycinMutagensEthylnitrosoureaCell SurvivalNitrosourea CompoundsThiotepaMethyltransferasesMitomycinsDrug SynergismDose-Response Relationship, DrugPhosphoramide MustardsCombined Modality TherapyPlatinumTriaziquoneDrug Screening Assays, AntitumorDrug Administration ScheduleMustard GasIfosfamideDNATumor Cells, CulturedAziridinesEtoposideEtanidazoleDoxorubicinCell Line, TumorOvarian NeoplasmsDNA GlycosylasesDNA Modification MethylasesDNA Repair EnzymesVinblastinePropiolactoneLung NeoplasmsLomustineEthylmaleimideTreatment OutcomeNylonsLeukopeniaNimustineNeoplasms, Second PrimaryApoptosisMethionine SulfoximineCarboplatinButhionine SulfoximineCricetinaeFluorouracilCross-Linking ReagentsBrain NeoplasmsLeukemia L1210GliomaPaclitaxelNeoplasmsGlutathionePoly(ADP-ribose) PolymerasesSarcoma, YoshidaPorfiromycinSurvival AnalysisMesylatesMutationDNA, NeoplasmQuinacrine MustardDicumarolRadiotherapy4-Nitroquinoline-1-oxideBleomycinCell LineVincristineDeoxycytidineN-Glycosyl HydrolasesDisease-Free SurvivalLeukemia, Radiation-InducedInfusions, IntravenousGlioblastomaLeukemia L5178MitolactolDrug Evaluation